• / Free eNewsletters & Magazine
  • / My Account
Home>Harwood Feffer LLP Announces Investigation of PDL BioPharma, Inc.

Harwood Feffer LLP Announces Investigation of PDL BioPharma, Inc.

3party Content

Sat, 20 Sep 2014

NEW YORK, Sept. 19, 2014 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) concerning whether the board has breached its fiduciary duties to shareholders or violated the
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.